Formulary Search
A to Z of Drugs : H
Records returned : 72 (on 28 May 2025 at 05:43:43).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
- Tablets
Restrictions / Comments:
Important
Includes tic disorders, tremors, Tourette's syndrome, choreas, Huntington's disease, Huntington's chorea
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Includes tic disorders, tremors, Tourette's syndrome, choreas, Huntington's disease, Huntington's chorea
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Test kit
Restrictions / Comments:
Important
SASH / East Surrey Place only - through the LCS
SASH / East Surrey Place only through the LCS
Links :
Indication :
Status :
Formulations :
- Intravenous flush
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Mouthwash
Restrictions / Comments:
Important
Available to purchase for self care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making a formulary application.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making a formulary application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Acarizax - RSFT Immunology and specialist paediatricians only. Approved in over 18s only. Licensed in children over 12 years.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Acaroid - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sublingual tablets
Restrictions / Comments:
Important
Lais sublingual tablets - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
- Sublingual tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intra-articular injection
Restrictions / Comments:
Important
ASPH rehumatology only - Ostenil, Viscoseal and Synvisc
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Transfer of prescribing to primary care only after initiation and stabilisation by the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribing in primary care on specialist recommendation only.
Reserved for severe / resistant hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Hypertensive emergency (including pregnancy) or hypertension with renal complications
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Hypertensive emergency (including pregnancy) or hypertension with renal complications
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Hydrocortisone sodium phosphate by intramuscular injection
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Hydrocortisone sodium succinate by intramuscular injection.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Hydrocortisone sodium phosphate by intravenous injection
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Hydrocortisone sodium succinate by intravenous injection.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Initial supply from the initiating Trust. Primary Care may prescribe replacement supplies for patients who have clear, written instructions and a management plan has been provided to the GP.
Hydrocortisone sodium phosphate by intramuscular injection - does NOT require reconstitution.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Initial supply from the initiating Trust. Primary Care may prescribe replacement supplies for patients who have clear, written instructions and a management plan has been provided to the GP.
Hydrocortisone sodium succinate by intramuscular injection. Comes in a powder that requires reconstitution (may be less suitable for rescue kits)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Granules in capsules for opening
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For infants / children on doses BELOW 5mg. Capsules for opening. 0.5mg, 1mg and 2mg only.
Doses of 5mg or more - to halve a 10mg tablet and use lower strength capsules to achieve correct dose. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
See PAD for guidance on providing reserve supplies for dosing during acute illness
Can be halved for doses of 5mg. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients on dose of 10mg AND unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Primary Care may initiate prescribing on request from the specialist endocrinology team.
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in infants and children where smaller doses are required.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
(MHRA drug safety update December 2018) https://www.gov.uk/drug-safety-update/hydrocortisone-muco-adhesive-buccal-tablets-should-not-be-used-off-label-for-adrenal-insufficiency-in-children-due-to-serious-risks
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Primary Care may initiate prescribing on request from the specialist endocrinology team.
Links :
Indication :
Status :
Formulations :
- Granules in capsules for opening
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For infants / children on doses BELOW 5mg. Capsules for opening. 0.5mg, 1mg and 2mg only.
Doses of 5mg or more - to halve a 10mg tablet and use lower strength capsules to achieve correct dose. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
See PAD for guidance on providing reserve supplies for dosing during acute illness
10mg tablets can be halved for doses of 5mg. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For patients on dose of 10mg AND unable to swallow solid dose forms.
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
For use in infants and children where smaller doses are required.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
(MHRA drug safety update December 2018) https://www.gov.uk/drug-safety-update/hydrocortisone-muco-adhesive-buccal-tablets-should-not-be-used-off-label-for-adrenal-insufficiency-in-children-due-to-serious-risks
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Buccal tablets
Restrictions / Comments:
Important
Available to purchase for self care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Solution
Restrictions / Comments:
Important
6% solution, diluted for use as a mouthwash
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Preferred
https://www.toxbase.org/ .
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Not for use after gastric band surgery.
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Initiation and 3 months of treatment to be provided by specilaist team before any requests for primary care prescribing.
500mg capsules.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Off-label use in Sickle Cell. Initiation and stabilisation (3 months) by the specialist team before any request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Sickle Cell in paediatrics - on advice from tertiary centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Tablets are considerably more expensive than capsules which have been agreed for off-label use in Sickle Cell.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intra-ocular injection
Restrictions / Comments:
Important
Medical device. May / may not be obtained through Pharmacy.
ASPH = Viscoat. RSFT = Viscoat / OcuCoat. SASH = Methylvisc
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Intramuscular injection (IM)
- Tablets
Restrictions / Comments:
Important
Injection - serious risk of adverse effects in underlying cardiac disease
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use. On advice from palliative care specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Patches
- Tablets
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
Restrictions / Comments:
Important
100mcg per ml. Unlicensed formulation.
Links :
Indication :
Status :
Formulations :
- Patches
- Tablets
Restrictions / Comments:
Important
Off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
Restrictions / Comments:
Important
300mcg/5ml. Unlicensed formulation. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
Links :
Indication :
Status :
Formulations :
- Patches
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Mild dry eye. Prescribe by brand (primary care)
- 1st line: Aapromel 0.3% or Aaculose 0.3%
- 2nd line: Lumecare 0.3%
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Mild dry eye. Prescribe by brand (primary care)
1st line = AddTear or Ocufresh preservative free 0.3%
2nd line = Hypromol preservative free 0.3%
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
Restrictions / Comments:
Important
Mild dry eye.
Prescribe by brand (primary care) as Lumecare Singles Hypromellose.
Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
Formulary Status :
Links :